Seminars in Pediatric Neurology
Volume 17, Issue 1 , Pages 35-38 , March 2010

A “Happy” Toddler Presenting With Sudden, Life-Threatening Seizures

  • Diane Stein, MD

      Affiliations

    • Pediatric Neurology, Southern California Permanente Medical Group, Kaiser Permanente Hospital Bellflower, Bellflower, CA
    • ,
  • Malini Chetty, RD

      Affiliations

    • Pediatric Neurology, Southern California Permanente Medical Group, Kaiser Permanente Hospital Bellflower, Bellflower, CA
    • ,
  • Jong M. Rho, MD

      Affiliations

    • Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, Phoenix, AZ
    • Corresponding Author InformationAddress reprint requests to Jong M. Rho, MD, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, 500 W. Thomas Road, Suite 400, Phoenix, AZ 85013

References 

  1. Lawson-Yuen A, Wu BL, Lip V, et al. Atypical cases of Angelman syndrome. Am J Med Genet A. 2006;140:2361–2364
  2. Paprocka J, Jamroz E, Szwed-Bialozyt B, et al. Angelman syndrome revisited. Neurologist. 2007;13:305–312
  3. Guerrini R, Carrozzo R, Rinaldi R, et al. Angelman syndrome: Etiology, clinical features, diagnosis, and management of symptoms. Paediatr Drugs. 2003;5:647–661
  4. Angelman H. “Puppet children.” A report of 3 cases. Dev Med Child Neurol. 1965;7:681–688
  5. Laan LA, Vein AA. Angelman syndrome: Is there a characteristic EEG?. Brain Dev. 2005;27:80–87
  6. Munoz-Cabello B, Rufo-Campos M, Madruga-Garrido M, et al. Epileptic seizures in Angelman syndrome. Rev Neurol. 2008;47:113–118
  7. Pelc K, Boyd SG, Cheron G, et al. Epilepsy in Angelman syndrome. Seizure. 2008;17:211–217
  8. Lalande M, Calciano MA. Molecular epigenetics of Angelman syndrome. Cell Mol Life Sci. 2007;64:947–960
  9. Freeman JM, Veggiotti P, Lanzi G, et al. The ketogenic diet: From molecular mechanisms to clinical effects. Epilepsy Res. 2006;68:145–180
  10. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol. 2008;7:500–506
  11. Hartman AL, Vining EP. Clinical aspects of the ketogenic diet. Epilepsia. 2007;48:31–42
  12. Caraballo RH, Cersósimo RO, Sakr D, et al. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic Disord. 2006;8:151–155
  13. Kossoff EH, Hedderick EF, Turner Z, et al. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia. 2008;49(9):1504–1509
  14. Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia. 2002;43:103–104
  15. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48:43–58
  16. Yudkoff M, Daikhin Y, Melø TM, et al. The ketogenic diet and brain metabolism of amino acids: Relationship to the anticonvulsant effect. Annu Rev Nutr. 2007;27:415–430
  17. Williams CA. Neurological aspects of the Angelman syndrome. Brain Dev. 2005;27:88–94
  18. Ferguson C, Hardy SL, Werner DF, et al. New insight into the role of the beta3 subunit of the GABAA-R in development, behavior, body weight regulation, and anesthesia revealed by conditional gene knockout. BMC Neurosci. 2007;8:85
  19. DeLorey TM, Olsen RW. GABA and epileptogenesis: Comparing GABRB3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res. 1999;36:123–132
  20. Handforth A, Delorey TM, Homanics GE, et al. Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3-deficient mice, a model of Angelman syndrome. Epilepsia. 2005;46:1860–1870
  21. White HS, Smith MD, Wilcox KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol. 2007;81:85–110
  22. Dion MH, Novotny EJ, Carmant L, et al. Lamotrigine therapy of epilepsy with Angelman's syndrome. Epilepsia. 2007;48:593–596
  23. Franz DN, Glauser TA, Tudor C, et al. Topiramate therapy of epilepsy associated with Angelman's syndrome. Neurology. 2000;54:1185–1188
  24. Kuenzle C, Steinlin M, Wohlrab G, et al. Adverse effects of vigabatrin in Angelman syndrome. Epilepsia. 1998;39:1213–1215
  25. Wang JF, Sun X, Chen B, et al. Lamotrigine increases gene expression of GABA-A receptor beta3 subunit in primary cultured rat hippocampus cells. Neuropsychopharmacology. 2002;26:415–421
  26. Sankar R, Rho JM. Do seizures affect the developing brain?: Lessons from the laboratory. J Child Neurol. 2007;22(5 Suppl):21S–29S

PII: S1071-9091(10)00009-4

doi: 10.1016/j.spen.2010.02.002

Seminars in Pediatric Neurology
Volume 17, Issue 1 , Pages 35-38 , March 2010

Article Tools